Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Unknown 1

Sponsor Class

INDUSTRY 96OTHER 41NIH 2UNKNOWN 1NETWORK 1INDIV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Lung Neoplasms 4Carcinoma, Non-Small-Cell Lung 3Neoplasm Metastasis 2Squamous Cell Carcinoma of Head and Neck 1Small Cell Lung Carcinoma 1Prostate Cancer Metastatic 1Oropharyngeal Neoplasms 1Oligometastatic Squamous Cell Carcinoma of the Head and Neck 1Neoplasm, Residual 1Mouth Neoplasms 1Mesothelioma 1Melanoma 1Leukemia, Myeloid, Chronic-Phase 1Laryngeal Neoplasms 1Hypopharyngeal Neoplasms 1Hodgkin Disease 1Gallbladder Neoplasms 1Colorectal Neoplasms 1Clear-cell metastatic renal cell carcinoma 1Carcinoma, Renal Cell 1Carcinoma 1Breast Neoplasms 1Biliary Tract Neoplasms 1Anatomic Stage I Breast Cancer AJCC v8 1

Interventions

Fluorouracil 29Leucovorin 26Oxaliplatin 25Capecitabine 16Irinotecan 14Cetuximab 10Bevacizumab 9Radiotherapy 8Panitumumab 5Folfox protocol 5Surgical Procedures, Operative 3Levamisole 3Celecoxib 3tremelimumab 2neratinib 2napabucasin 2durvalumab 2cediranib 2aflibercept 2X-Rays 2Tegafur 2Radiofrequency Ablation 2Psychiatric Rehabilitation 2Preoperative Exercise 2Octreotide 2Mitomycin 2Interviews as Topic 2Immunoglobulin G 2Folic Acid 2Floxuridine 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Colorectal Neoplasms × pembrolizumab × Clear all
NCT03626922 2022-06-10

Study of Pembrolizumab With Pemetrexed and Oxaliplatin in Chemo-Refractory Metastatic Colorectal Cancer Patients

NSABP Foundation Inc

Phase 1 Unknown
33 enrolled
Gastrointestinal

Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡